RA
ARNA

Rational Advisors’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Rational Advisors’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		$234K Sell
4,000
-6,500
-62% -$340K 0.02% 459
2013
Q3 		$553K Hold
10,500
– – 0.04% 378
2013
Q2 		$809K Buy
+10,500
New +$857K 0.07% 339

Other funds holding ARNA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
SC
Samlyn Capital New York $5.86B AUM 36.3% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Rational Advisors's ARNA Position: Q4 2013 in Review

Rational Advisors reduced its Arena Pharmaceuticals Inc (ARNA) stake by 62% in Q4 2013, selling an estimated $340K and leaving 4,000 shares worth $234K. The position accounts for 0.02% of the portfolio, ranked #459.

Rational Advisors first reported a position in ARNA in Q2 2013 and has held it in 3 quarters since. The position peaked at $809K in Q2 2013. 134 funds tracked by Wall St. Rank hold ARNA as of Q4 2013.

  • Rational Advisors held 4,000 shares of Arena Pharmaceuticals Inc worth $234K as of Q4 2013.
  • Rational Advisors sold 6,500 Arena Pharmaceuticals Inc shares in Q4 2013, an estimated $340K.
  • Arena Pharmaceuticals Inc made up 0.02% of Rational Advisors's portfolio in Q4 2013, its #459 holding.
  • Rational Advisors first reported a position in Arena Pharmaceuticals Inc in Q2 2013 and has held it in 3 quarters since.
  • Rational Advisors's Arena Pharmaceuticals Inc position peaked at $809K in Q2 2013.
  • 134 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q4 2013.

Based on Rational Advisors's 13F filing for Q4 2013, filed 17 Feb 2015.